NASDAQ: CUPRCuprina Holdings Ltd Stock
$4.54-0.31 (-6.39%)
Updated Apr 22, 2025
CUPR Price
$4.54
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$3.51
52 Week High
$5.81
P/E
-81.14x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$71.92k
Earnings
-$1.01M
Gross Margin
35.7%
Operating Margin
-1,317.46%
Profit Margin
-1,412.1%
Debt to Equity
-1.47
Operating Cash Flow
-$1M
Beta
-1.51
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CUPR Overview
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CUPR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Biotech
Industry Rating
F
CUPR
Ranked#117 of 463
Ranked#117 of 463
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $2.63 | A | |
| $7.89 | A | |
| $22.60 | A |
Be the first to know about important CUPR news, forecast changes, insider trades & much more!
CUPR News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CUPR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CUPR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CUPR is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CUPR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CUPR due diligence checks available for Premium users.
Valuation
CUPR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-81.14x
Industry
-208.37x
Market
28.14x
CUPR's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CUPR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CUPR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.2M
Liabilities
$3.9M
Debt to equity
-1.47
CUPR's short-term liabilities ($3.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CUPR's short-term assets ($1.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CUPR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CUPR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
CUPR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
Cuprina Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.